Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine
Go back to Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 8.89 +0.33 (3.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.56 | 52 Week High | $9.23 | |||
| Open | $8.54 | 52 Week Low | $1.16 | |||
| Day High | $8.90 | P/E | N/A | |||
| Day Low | $8.45 | EPS | $-0.30 | |||
| Volume | 1,904,519 | |||||
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 8.89 +0.33 (3.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.56 | 52 Week High | $9.23 | |||
| Open | $8.54 | 52 Week Low | $1.16 | |||
| Day High | $8.90 | P/E | N/A | |||
| Day Low | $8.45 | EPS | $-0.30 | |||
| Volume | 1,904,519 | |||||

